Cancer, Metastatic clinical trials at UCSD
2 in progress, 1 open to eligible people
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
open to eligible people ages 18 years and up
The purpose of this study is to compare any good or bad effects of using pembrolizumab (an experimental drug) and radiation therapy (RT), compared to using cisplatin chemotherapy and radiation therapy (RT) in the treatment of patients with head and neck squamous cell carcinoma (HNSCC).
La Jolla, California
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Sorry, not yet accepting patients
This study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.
Last updated: